Admin

``` As the “leader” in the recombinant collagen track, Jinbo Bio’s 2025 performance report has caused the market to sense a hint of unease. On April 30, Jinbo Bio released its 2025 financial report showing revenue for the period at 1.595 billion yuan, with a year-on-year growth of only

``` After the market closed on April 29th, Ninebot officially disclosed its first quarter report for 2026. Financial data shows that during the reporting period, the company achieved operating revenue of 5.87 billion yuan, a year-on-year increase of 14.82%; net profit attributable to shareholders of the listed company was

On April 29, Youngor released its first quarter report for 2026. The report shows that the company achieved operating revenue of 2.882 billion yuan in the first quarter, a year-on-year increase of 3.10%; net profit attributable to the parent was 922 million yuan, a year-on-year increase of 14.

April 29, Ellassay Fashion released its 2026 Q1 financial report. According to the report, the company achieved operating revenue of 744 million yuan in the first quarter, a year-on-year increase of 7.77%; net profit attributable to the parent company was 41.0011 million yuan, a slight year-on-year increase of

Brent crude hits a nearly four-year high, the Federal Reserve stays hawkish yet unmoved and reveals internal disagreements, and tech giants' earnings are mixed—on Thursday, global markets were hit by violent shocks from multiple directions, and investors struggled to find direction between escalating geopolitics, expectations of tighter monetary

``` Author | Huang Yu After being acquired by Zhiyuan Robotics and its core executives, Shangwei New Materials became the "hot commodity," but as expected, it entered a period of performance pain. On April 29, Shangwei New Materials released its Q1 2026 financial report. The report shows that its operating